CN Stock MarketDetailed Quotes

Anhui Anke Biotechnology (300009)

Watchlist
  • 8.84
  • -0.11-1.23%
Market Closed Apr 30 15:00 CST
14.77BMarket Cap21.30P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Anhui Anke Biotechnology (300009) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Genetic engineering drug1.94B73.20%
Other465.69M17.60%
External paste243.65M9.21%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Biological products1.98B74.81%
Chinese patent medicine289.17M10.93%
Chemical synthetic drugs150.25M5.68%
Raw material medicine101.58M3.84%
Other100.88M3.81%
Technical services24.73M0.93%
View all

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Domestic sales2.64B99.86%
Other operating income3.19M0.12%
Foreign sales513.03K0.02%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Iran has announced its latest negotiation proposal: all issues should be resolved within 30 days, with the focus placed on 'ending the war' Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -